ABHD16B
ABHD16B
Also known as: ABHGB_HUMAN, C20orf135, dJ591C20.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3Z7
- Gene
- ABHD16B
- Ensembl
- ENSG00000183260
- Chromosome
- 20
- Canonical length
- 469 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable monoacylglycerol lipase activity and phospholipase activity. Predicted to be involved in monoacylglycerol catabolic process and phosphatidylserine catabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
469 residues, UniProt reviewed canonical sequence.
>Q9H3Z7|ABHD16B
1 MCVICFVKAL VRVFKIYLTA SYTYPFRGWP VAFRWDDVRA VGRSSSHRAL TCAAAAAGVW
61 LLRDETLGGD ALGRPPRGAR SQAQCLLQQL RELPGQLASY ALAHSLGRWL VYPGSVSLMT
121 RALLPLLQQG QERLVERYHG RRAKLVACDG NEIDTMFMDR RQHPGSHVHG PRLVICCEGN
181 AGFYEMGCLS APLEAGYSVL GWNHPGFGSS TGVPFPQHDA NAMDVVVEYA LHRLHFPPAH
241 LVVYGWSVGG FTATWATMTY PELGALVLDA TFDDLVPLAL KVMPHSWKGL VVRTVREHFN
301 LNVAEQLCCY PGPVLLLRRT QDDVVSTSGR LRPLSPGDVE GNRGNELLLR LLEHRYPVVM
361 AREGRAVVTR WLRAGSLAQE AAFYARYRVD EDWCLALLRS YRARCEEELE GEEALGPHGP
421 AFPWLVGQGL SSRRRRRLAL FLARKHLKNV EATHFSPLEP EEFQLPWRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD16B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- testis: 15 nTPM
- spleen: 3.4 nTPM
- appendix: 2.4 nTPM
- stomach: 2.1 nTPM
- adipose tissue: 2 nTPM
- pancreas: 2 nTPM
Single-cell type
- late spermatids: 432 nCPM
- early spermatids: 158 nCPM
- late primary spermatocytes: 28 nCPM
- epicardial cells: 2.3 nCPM
- cardiomyocytes: 2.2 nCPM
- peritubular myoid cells: 2.2 nCPM
Immune cell
- eosinophil: 2.7 nTPM
- T-reg: 0.8 nTPM
- total PBMC: 0.8 nTPM
- classical monocyte: 0.7 nTPM
- gdT-cell: 0.7 nTPM
- myeloid DC: 0.6 nTPM
Brain region
- thalamus: 17 nTPM
- cerebral cortex: 12 nTPM
- pons: 11 nTPM
- midbrain: 11 nTPM
- amygdala: 11 nTPM
- hypothalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD16B as an antibody target. Whether an autoantibody or antibody against ABHD16B could matter depends on whether native ABHD16B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD16B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABHD16B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...